News-Papers
Testimonial
Video Gallery
Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions
Published on Friday, 21 July 2017
Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions
See also:
- All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives);
- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;
- Vitamin D (analogues and/or derivatives) and cancer;
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report;
Search
Follow us...
Latest
- Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
- Molecular aspects of melatonin (MLT)-mediated therapeutic effects
- Molecular mechanisms of melatonin anticancer effects
- Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review
- Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis
- Physiological Effects of Melatonin: Role of Melatonin Receptors and Signal Transduction Pathways
- Plasma melatonin and the hormone-dependency of human breast cancer
- Melatonin Inhibits the Progression of Oral Squamous Cell Carcinoma via Inducing miR-25-5p Expression by Directly Targeting NEDD9
- Potential role of melatonin in prevention and treatment of oral carcinoma
- Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients
- Somatostatin in oncology, the overlooked evidences
- Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status
- Repercussions of melatonin on the risk of breast cancer: a systematic review and meta-analysis
- Role of Melatonin in Breast Carcinoma: Correlation of Expression Patterns of Melatonin-1 Receptor With Estrogen, Progesterone, and HER2 Receptors
- The oncogenic potential of autocrine human growth hormone in breast cancer
- Chronic lymphocytic leukemia: long-lasting remission with combination of cyclophosphamide, somatostatin, bromocriptine, retinoids, melatonin, and ACTH
- The Di Bella Method improved survival, objective response and performance status in a retrospective observational clinical study on 23 tumours of the head and neck
- Recurrent Glioblastoma Multiforme (grade IV - WHO 2007): a case of complete objective response - concomitant administration of Somatostatin/Octreotide, Retinoids, Vit E, Vit D3, Vit C, Melatonin, D2 R agonists (Di Bella Method - DBM) associated with Temol
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer